MIMO Biosciences, member of Navarra Health Cluster, celebrated its first year of activity in February — a journey already marked by key milestones, including its
Navarra Health Cluster and its member entity Asphalion launched a new training cycle titled “Regulatory Challenges in Pharmaceutical and Healthcare Innovation” on Tuesday 1 April,
The entity’s General Assembly, held this Friday, revealed that the number of member organizations in the last fiscal year was 54. Their combined turnover exceeded
The presence of Navarra Health Cluster at the FITECU 2025 fair has been an enriching experience full of learning. Our main objective has been to
What are nanoantibodies and how can they be used to develop treatments for skin diseases? Nicolás Galmarini, CEO and co-founder of Nanogrow, an entity associated
On the occasion of World Stroke Day, the Brain Damage Association of Navarra (Adacen), a member of Navarra Health Cluster, brought together companies and knowledge